This book is the first title that focuses exclusively on kidney disease and its impact in the cardiac catheterization laboratory. The increasing prevalence of vascular risk factors such as diabetes, obesity and hypertension coupled with increased longevity has resulted in a worldwide epidemic of cardiovascular and chronic kidney disease (CKD). Never has the impact of one organ system on the other been so profound, as in the current context of cardio-renal interactions. The cross talk between the heart and kidneys is highly relevant in the field of interventional cardiology, given the increasing number of trans-catheter procedures being performed in patients with underlying kidney disease. These procedures also have a significant impact on kidney function and require thoughtful interdisciplinary planning by a cardiorenal team, to achieve optimal outcomes This book assembles the collective expertise of several international leaders in the field of interventional cardiology and nephrology to summarize this complex interface. The book is divided into seven sections to comprehensively cover the topic, including sections on best practices with reduction of contrast associated acute kidney injury, cutting edge techniques to minimize kidney risk with complex interventions, impact of transcatheter valvular procedures on kidney function and the utility of cardio-nephrology teams . Less recognized complications with high morbidity such as athero-embolic renal disease are featured prominently, to increase awareness in the interventional cardiology and nephrology communities. This book is a valuable resource for interventional and structural cardiologists, general cardiologists and nephrologists dealing with the significant overlap areas between these two specialties. It is also relevant to medical students, trainee physicians in nephrology and cardiology, advanced care practitioners and nursing personnel in both specialties . Given the major impact of kidney function on outcomes in patients undergoing cardiac procedures, this textbook serves as a focal point to integrate relevant clinical data from both specialties and help interventional cardiologists achieve optimal outcomes, especially in patients with (or at risk for) kidney disease.

Interventional cardiologists are able to perform minimally invasive procedures, such as angioplasty and stenting, due to imaging technologies that allow them to see inside the heart and blood vessels without open surgery. Such imaging often requires injection of contrast media, which are generally safe, but for some patients with drug sensitivities or compromised kidney function, contrast-induced nephropathy (CIN) can result. CIN is a major complication that can increase in-hospital mortality. This issue of Interventional Cardiology Clinica addresses the management, treatment, and prevention of renal complications in the catheterization laboratory.

This issue of Interventional Cardiology Clinics, guest edited by Dr. Hitinder Gurm, will discuss Renal Disease and coronary, peripheral and structural interventions. This issue is one of four selected each year by the series Editor-in-Chief, Dr. Matthew Price. Topics discussed in this issue will include: Contrast induced nephropathy, Pathophysiology of CIN, Implications of Renal disease in patients undergoing peripheral arterial interventions, Implications of renal disease in patients undergoing Structural interventions, Different types of contrast media, Biomarkers of CIN, Pharmacological prophylaxis of CIN, A practical approach to preventing renal complications in the catheterization laboratory, and several other topics.

In this issue of Interventional Cardiology Clinics, guest editor Dr. Shweta Bansal brings her considerable expertise to the topic of Renal Disease and Coronary, Peripheral and Structural Interventions. Top experts cover key topics such as the significance of kidney disease in cardiovascular disease patients; definition and stages of AKI in context of cardiovascular procedures; contrast-induced/associated nephropathy; predicting contrast-induced renal complications; hydration IV and oral/other pharmacological preventive strategies; and more. - Contains 10 relevant, practice-oriented topics including the implications of renal disease in patients undergoing peripheral arterial interventions; the implications of renal disease in patients undergoing structural interventions; a practical approach to preventing renal complications in the catheterization laboratory; AKI management strategies pericardiovascular interventions[RM1] ; and more. - Provides in-depth clinical reviews on renal disease and coronary, peripheral and structural interventions, offering actionable insights for clinical practice. - Presents the latest information on this timely, focused topic under the leadership of experienced editors in the field. Authors synthesize and distill the latest research and practice guidelines to create clinically significant, topic-based reviews.

Contrast nephropathy is a major and growing problem. It is the third most common cause of in-hospital acute renal failure and is associated with significant in-hospital mortality, long-term mortality, increased risk of in-hospital major adverse cardiac events as well as prolonged hospital stay and increased costs of health care. The first of its kind to discuss the potentially mortal problems with contrast agent-induced nephropathy, this important work focuses on the challenge of contrast nephropathy in patients undergoing diagnostic and interventional procedures in the cardiac catheterization laboratory, such as coronary and peripheral angiography, percutaneous coronary and peripheral interventions. Bringing together experts from the specialties and subspecialties of cardiology, interventional cardiology, radiology and nephrology, Contrast-Induced Nephropathy is a useful resource not only for interventional cardiologists but also for other professionals involved in the care of high-risk patients undergoing contrast-associated procedures.

Extending from the outpatient management of cardiovascular and kidney disease, to hospital-based decision making in patients with cardio-renal disease and complex interfaces such as hemodialysis in patients with ventricular assist device support, this book serves as a single reference point for cardiology and nephrology clinicians and researchers dealing with the significant overlap areas between these two specialties. Chapters cover the physiology, biomarkers, therapeutic agents and full spectrum of these comorbidities and feature separate sections on cardiovascular and CKD evaluations, stratification of kidney transplant patients, lipid management in CKD, interventional strategies and hypertension. Leaders in cardiology, nephrology, hypertension and lipidology bring together the latest evidence with their collective clinical experience into this invaluable resource.This textbook is an essential resource for physicians and allied professionals practicing cardiology, nephrology, students and physician trainees, to deepen their understanding of this crucial field.

This issue of Interventional Cardiology Clinics, guest edited by Dr. Hitinder Gurm, will discuss Renal Disease and coronary, peripheral and structural interventions. This issue is one of four selected each year by the series Editor-in-Chief, Dr. Matthew Price. Topics discussed in this issue will include: Contrast induced nephropathy, Pathophysiology of CIN, Implications of Renal disease in patients undergoing peripheral arterial interventions, Implications of renal disease in patients undergoing Structural interventions, Different types of contrast media, Biomarkers of CIN, Pharmacological prophylaxis of CIN, A practical approach to preventing renal complications in the catheterization laboratory, and several other topics.

Known worldwide, chronic kidney disease (CKD) is a disease that affects up to 4% of the population with increasing figures also in the developing countries. Life expectancy of patients affected by CKD is shortened compared to the overall population, and only a minority of patients reach end-stage renal disease (ESRD) with the need for dialysis or renal transplantation; death overtakes dialysis. In the 13 chapters, this book sheds light on the different aspects related to pathophysiology and clinical aspects of CKD, providing interesting insights into not only inflammation and cardiovascular risk but also the interplay of hormones and the functional aspects of endothelial function. In addition, chapters dealing with genetic aspects of polycystic kidney disease and also the clinical handling of patients with CKD and peritoneal dialysis will be beneficial for the open-minded reader.

This book is open access under a CC BY 4.0 license. This quick-reference handbook offers a concise and practical review of key aspects of the treatment of ST-segment elevation myocardial infarction (STEMI) in the era of primary percutaneous coronary intervention (PPCI). In the context of STEMI, PPCI is the preferred mode of emergency revascularization. Access to PPCI is rapidly increasing and is now routinely practiced in both general and specialist hospitals and there has been a recent emphasis on developing STEMI networks to enhance and expedite the referral pathway. This coupled with concurrent developments to enhance the safety and efficacy of the PPCI procedure has heralded an era where STEMI interventions are increasingly considered an important subspecialty within interventional cardiology. Written by leading cardiologists who have been instrumental in the adoption of PPCI in their respective institutions, the book provides junior and senior cardiologists alike with insightful and thought-provoking tips and tricks to enhance the success of PPCI procedures, which may in turn translate into direct improvements in outcomes. The book is also relevant for healthcare providers and emergency department physicians.